Actually, it is important to remind the remarkable progresses achieved in the treatment of Ph-positive ALL after the development of ABL TKi, whose introduction dramatically improved the prognosis, with disease-free survival in pediatric patients exceeding 70% [3]. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.